Mogroside IV-E

Overview

Mogroside IV-E is a PUS1 inhibitor that reduces PUS1 expression and inhibits bone metastasis of prostate cancer . Mogroside IV-E can be used in prostate cancer-related research.

Application

Products | Products > Disease Areas > Cancer | Products > Disease Areas > Urogenital Disease | Products > Disease Areas > Prostate Cancer | Products > Disease Areas > Urogenital Cancer | Products > Signaling Pathways > Cell Cycle/DNA Damage | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Signaling Pathways > DNA/RNA Synthesis

Product Information

• Catalog No.: HY-N2456
• CAS No.: 88915-64-4
• Molecular Formula: C54H92O24
• Molecular Weight: 1125.29
• Purity: 99.71%
• Storage: 4°C, protect from light * In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
• Solubility: ≥ 2.5 mg/mL (2.22 mM); Clear solution
• Availability: In-stock

Source

Original product source